AXIM Biotechnologies Inc (AXIM)
0.0122
0.00 (0.00%)
USD |
OTCM |
May 02, 15:56
AXIM Biotechnologies Debt to Equity Ratio: -0.7396 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.7396 |
| September 30, 2023 | -0.9334 |
| June 30, 2023 | -0.5583 |
| March 31, 2023 | -0.8669 |
| December 31, 2022 | -1.170 |
| September 30, 2022 | -1.273 |
| June 30, 2022 | -1.485 |
| March 31, 2022 | -1.604 |
| December 31, 2021 | -2.841 |
| September 30, 2021 | 1.328 |
| June 30, 2021 | 5.704 |
| March 31, 2021 | 3.845 |
| December 31, 2020 | 3.946 |
| September 30, 2020 | 2.665 |
| June 30, 2020 | 5.462 |
| March 31, 2020 | -17.79 |
| December 31, 2019 | -0.748 |
| September 30, 2019 | -0.976 |
| June 30, 2019 | -0.9666 |
| March 31, 2019 | -1.124 |
| December 31, 2018 | -0.9648 |
| September 30, 2018 | -0.7469 |
| June 30, 2018 | -0.8028 |
| March 31, 2018 | -0.8124 |
| December 31, 2017 | -1.019 |
| Date | Value |
|---|---|
| September 30, 2017 | -1.266 |
| June 30, 2017 | -1.718 |
| March 31, 2017 | -0.6292 |
| December 31, 2016 | -0.7474 |
| September 30, 2016 | -0.4318 |
| June 30, 2016 | -0.4912 |
| March 31, 2016 | -0.5623 |
| December 31, 2015 | -0.896 |
| September 30, 2015 | -1.901 |
| June 30, 2015 | 1.718 |
| March 31, 2015 | -0.9984 |
| December 31, 2014 | -1.808 |
| September 30, 2014 | -5.558 |
| June 30, 2014 | -0.9968 |
| March 31, 2014 | -9.264 |
| December 31, 2013 | -0.5324 |
| September 30, 2013 | -0.9813 |
| June 30, 2013 | -1.240 |
| March 31, 2013 | -4.755 |
| December 31, 2012 | -10.64 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-17.79
Minimum
Mar 2020
5.704
Maximum
Jun 2021
-0.4735
Average
-0.8669
Median
Mar 2023
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.122M |
| Total Liabilities (Quarterly) | 11.78M |
| Shareholders Equity (Quarterly) | -7.657M |
| Current Ratio | 0.0262 |
| Net Debt Paydown Yield | -0.37% |